Fungal infections are common during pregnancy due to the natural physiological and hormonal shifts in a woman's body. High estrogen levels increase glycogen content in the vaginal epithelium, creating an ideal environment for yeast proliferation, particularly Candida species. As midwives in Nigeria, recognizing when these opportunistic infections require pharmacological intervention is vital for maternal comfort and preventing neonatal complications during birth. Antifungal agents are substances used to treat fungal infections by either killing the fungus or stopping its growth. Unlike bacteria, fungi are eukaryotic organisms, meaning their cellular structure closely resembles human cells. This biochemical similarity makes the development of selective antifungal drugs challenging, as agents that disrupt fungal cells can sometimes affect maternal host cells. Therefore, understanding the distinct pharmacological classes, indications, and safety margins of these drugs is an essential component of antepartum and postpartum clinical care.
Antifungal drugs are categorized based on their chemical structure and how they target fungal cells. The major classes utilized in clinical practice include polyenes, azoles, and echinocandins. Each class disrupts fungal survival through distinct biochemical pathways.
Vulvovaginal candidiasis (VVC) is by far the most frequent fungal condition managed by midwives. Symptoms include intense vaginal itching, burning during micturition, and thick, white, curdy discharge resembling cottage cheese. Oral thrush and cutaneous candidiasis in skin folds also appear frequently due to localized warmth and moisture in tropical climates. During the puerperium, breastfeeding mothers may develop candidal mastitis, characterized by deep, shooting breast pain during and after feeds, accompanied by shiny or flaking pink nipple skin. Differentiating fungal nipple pain from bacterial mastitis or infant latch issues prevents misdiagnosis and ineffective antibiotic treatment.
Prescribing medication during pregnancy requires balancing therapeutic benefits against potential risks to the developing fetus. Topical azoles, such as clotrimazole and miconazole, are considered safe for first-trimester use because systemic absorption through the vaginal mucosa is minimal. Conversely, oral azoles like fluconazole carry teratogenic concerns when used in high or prolonged doses during early pregnancy, showing potential links to craniofacial and skeletal birth defects. Single-dose oral fluconazole for uncomplicated yeast infections has sparked safety debates, but international guidelines generally advise favoring multi-day topical treatments throughout the first trimester to maintain a wide margin of safety.
Correct administration routes ensure treatment efficacy while minimizing side effects. For localized vulvovaginal candidiasis in pregnant women, topical imidazoles are prescribed as 7-day courses rather than short 1-day regimens to ensure complete fungal eradication in the altered vaginal environment. Midwives must clearly instruct patients on how to insert vaginal pessaries using the provided applicator or clean fingers, preferably at bedtime so the medication stays in place longer. Oral antifungal therapy is strictly reserved for complicated or refractory cases after the first trimester, with strict adherence to prescribed dosing intervals by the attending clinician.
Superficial mycoses stay confined to the outer layers of skin, nails, and mucous membranes, responding well to topical creams and pessaries. Systemic mycoses invade deep internal organs and pose life-threatening risks to both mother and fetus, requiring aggressive inpatient management with intravenous agents like amphotericin B. Although systemic fungal infections like cryptococcosis or histoplasmosis are relatively rare in routine obstetric practice, they occur more frequently in immunocompromised women, such as those living with HIV. Midwives working in referral centers must identify systemic warning signs like persistent high fever, respiratory distress, and generalized malaise, ensuring prompt escalation to a physician.
Comprehensive midwifery care extends beyond prescription writing to include practical hygiene counseling and compliance monitoring. Midwives should advise patients to wear breathable cotton underwear, avoid tight synthetic trousers, and refrain from douching, which disrupts the normal protective vaginal flora. Educating women on completing the full course of topical therapy—even if itching stops after a few days—prevents recurrent infections. For breastfeeding mothers treated for nipple thrush, simultaneous treatment of the infant's oral thrush with prescribed nystatin drops is critical to prevent a continuous ping-pong reinfection cycle between mother and baby.